1,838
Total Claims
$749K
Drug Cost
337
Beneficiaries
$2,222
Cost/Patient
Peer Comparison vs. 5,101 Rheumatology providers
-13%
Opioid rate vs peers
3.5% vs 4.1% avg
-63%
Cost per patient vs peers
$2,222 vs $6,039 avg
Opioid Prescribing
3.5%
Opioid Rate
65
Opioid Claims
$330
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 1,643 claims · $75K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Infliximab | 19 | $181K |
| Infliximab-Dyyb | 13 | $140K |
| Tocilizumab | 23 | $50K |
| Hydroxychloroquine Sulfate | 396 | $33K |
| Methotrexate/Pf | 19 | $13K |
| Methotrexate Sodium | 211 | $7,335 |
| Leflunomide | 71 | $5,698 |
| Colchicine | 40 | $3,970 |
| Mycophenolate Mofetil | 22 | $2,698 |
| Sulfasalazine | 35 | $2,202 |
| Azathioprine | 32 | $2,177 |
| Celecoxib | 49 | $1,930 |
| Gabapentin | 86 | $1,750 |
| Pregabalin | 48 | $1,351 |
| Diclofenac Sodium | 36 | $1,208 |
Prescribing Profile
25
Unique Drugs
Patient Profile
67
Avg Age
75%
Female
1.77
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About